EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services
Keyword: Whole Blood
PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headqua… [+3796 chars]
Read Full Story ↗
Related Content
-
Related Story BK261357- SeCore CDx HLA Sequencing System
SaaS Metrics